Ingrese una palabra o frase en cualquier idioma 👆
Idioma:
Traducción y análisis de palabras por inteligencia artificial ChatGPT
En esta página puede obtener un análisis detallado de una palabra o frase, producido utilizando la mejor tecnología de inteligencia artificial hasta la fecha:
- cómo se usa la palabra
- frecuencia de uso
- se utiliza con más frecuencia en el habla oral o escrita
- opciones de traducción
- ejemplos de uso (varias frases con traducción)
- etimología
Qué (quién) es myelogenous pseudoleukemia - definición
ACUTE MYELOID LEUKEMIA CHARACTERIZED BY ACCUMULATION OF PROMYELOCYTES IN THE BONE MARROW AND BY A TRANSLOCATION BETWEEN CHROMOSOMES 15 AND 17
Acute promyelocytic leukaemia; Leukemia, promyelocytic, acute; Acute Promyelocytic Leukemia; Acute Promyeloid Leukaemia; Promyelocytic leukemia; M3 AML; Acute Promyelocytic Myelogenous Leukemia; AML-M3; APML; T(15;17); Acute myeloid leukemia with t(15;17)
![author=Syed Zaidi, M.D.}} Last author update: 1 February 2013 Last staff update: 29 November 2022</ref> [[Wright's stain]].](https://commons.wikimedia.org/wiki/Special:FilePath/Peripheral blood smear of acute promyelocytic leukemia, hypogranular variant.png?width=200 "author=Syed Zaidi, M.D.}} Last author update: 1 February 2013 Last staff update: 29 November 2022</ref> [[Wright's stain]].")
Accelerated phase chronic myelogenous leukemia
DISEASE
Accelerated phase chronic myelogenous leukemia is a phase of chronic myelogenous leukemia in which the disease is progressing. In this phase, 10 to 19% of the cells in the blood and bone marrow are blast cells (immature blood cells).
Leucocythemia
MYELOID LEUKEMIA THAT IS CHARACTERIZED BY THE RAPID GROWTH OF ABNORMAL WHITE BLOOD CELLS THAT ACCUMULATE IN THE BONE MARROW AND INTERFERE WITH THE PRODUCTION OF NORMAL BLOOD CELLS
Acute Myeloid Leukemia; Adult Acute Leukemia; Acute myelocytic leukemia; Acute myelogenous leukaemia; Acute nonlymphocytic leukemia; Acute myeloid leukaemia; Acute myeloid leukemia (generic term); Acute myeloid leukemia, secondary; Acute non lymphoblastic leukemia (generic term); Acute erythroblastic leukemia; Acute myeloblastic leukemia type 1; Acute myelogenous leukemia; Acute myeloblastic leukemia type 2; Acute myeloblastic leukemia type 3; Acute myeloblastic leukemia type 5; Acute myeloblastic leukemia type 4; Acute myeloblastic leukemia type 6; Acute myeloblastic leukemia type 7; Leukemia, myelocytic, acute; Acute myeloblastic leukemia type 0; Acute myeloic leukemia; Acute Myeloid Leukaemia; Leucocythemia; Myeloblastic leukemia; Acute myeloblastic leukemia; Therapy-related acute myeloid leukemia; Acute myeloid leukemia with prior myelodysplastic syndrome; Leukemia, myeloid, acute; ANLL; The genetic aspects of acute myeloid leukemia; Acute myeloid leukemia with recurrent genetic abnormalities
·noun A disease in which the white corpuscles of the blood are largely increased in number, and there is enlargement of the spleen, or the lymphatic glands; leuchaemia.
Acute myeloid leukemia
MYELOID LEUKEMIA THAT IS CHARACTERIZED BY THE RAPID GROWTH OF ABNORMAL WHITE BLOOD CELLS THAT ACCUMULATE IN THE BONE MARROW AND INTERFERE WITH THE PRODUCTION OF NORMAL BLOOD CELLS
Acute Myeloid Leukemia; Adult Acute Leukemia; Acute myelocytic leukemia; Acute myelogenous leukaemia; Acute nonlymphocytic leukemia; Acute myeloid leukaemia; Acute myeloid leukemia (generic term); Acute myeloid leukemia, secondary; Acute non lymphoblastic leukemia (generic term); Acute erythroblastic leukemia; Acute myeloblastic leukemia type 1; Acute myelogenous leukemia; Acute myeloblastic leukemia type 2; Acute myeloblastic leukemia type 3; Acute myeloblastic leukemia type 5; Acute myeloblastic leukemia type 4; Acute myeloblastic leukemia type 6; Acute myeloblastic leukemia type 7; Leukemia, myelocytic, acute; Acute myeloblastic leukemia type 0; Acute myeloic leukemia; Acute Myeloid Leukaemia; Leucocythemia; Myeloblastic leukemia; Acute myeloblastic leukemia; Therapy-related acute myeloid leukemia; Acute myeloid leukemia with prior myelodysplastic syndrome; Leukemia, myeloid, acute; ANLL; The genetic aspects of acute myeloid leukemia; Acute myeloid leukemia with recurrent genetic abnormalities
Acute myeloid leukemia (AML) is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal cells that build up in the bone marrow and blood and interfere with normal blood cell production. Symptoms may include feeling tired, shortness of breath, easy bruising and bleeding, and increased risk of infection.
Wikipedia
Acute promyelocytic leukemia
Acute promyelocytic leukemia (APML, APL) is a subtype of acute myeloid leukemia (AML), a cancer of the white blood cells. In APL, there is an abnormal accumulation of immature granulocytes called promyelocytes. The disease is characterized by a chromosomal translocation involving the retinoic acid receptor alpha (RARA) gene and is distinguished from other forms of AML by its responsiveness to all-trans retinoic acid (ATRA; also known as tretinoin) therapy. Acute promyelocytic leukemia was first characterized in 1957 by French and Norwegian physicians as a hyperacute fatal illness, with a median survival time of less than a week. Today, prognoses have drastically improved; 10-year survival rates are estimated to be approximately 80-90% according to one study.
